“Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture”. Tikrit Journal of Pharmaceutical Sciences 20, no. 1 (June 30, 2026): 20–32. Accessed August 8, 2026. https://tjphs.tu.edu.iq/index.php/j/article/view/689.